Clinical Trials Browser

Phase 2 × Multiple Myeloma × givinostat hydrochloride × Clear all

NCT00792506 2022-02-02

Phase II Clinical Trial of ITF2357 In Patients With Relapsed/Refractory Multiple Myeloma

Phase 2 Terminated

Multiple Myeloma